Found: 9
Select item for more details and to access through your institution.
Targeting MAPK in Cancer 2.0.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5702, doi. 10.3390/ijms23105702
- By:
- Publication type:
- Article
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 11259, doi. 10.3390/ijms222011259
- By:
- Publication type:
- Article
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 3, p. 938, doi. 10.3390/ijms21030938
- By:
- Publication type:
- Article
Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell Potential.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4372, doi. 10.3390/cancers13174372
- By:
- Publication type:
- Article
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation.
- Published in:
- FASEB Journal, 2023, v. 37, n. 8, p. e23061, doi. 10.1096/fj.202300323R
- By:
- Publication type:
- Article
Anti‐β4 integrin autoantibodies in patients with mucous membrane pemphigoid: A retrospective analysis from a tertiary centre in Italy.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. e249, doi. 10.1111/jdv.18617
- By:
- Publication type:
- Article
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 8, p. 1154, doi. 10.3390/cells12081154
- By:
- Publication type:
- Article
Lactate Maintains BCR/Abl Expression and Signaling in Chronic Myeloid Leukemia Cells Under Nutrient Restriction.
- Published in:
- Oncology Research, 2021, v. 29, n. 1, p. 33, doi. 10.3727/096504022X16442289212164
- By:
- Publication type:
- Article
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 5, p. 659, doi. 10.1007/s11523-020-00741-x
- By:
- Publication type:
- Article